Use of Eltrombopag in Children With Chronic Immune Thrombocytopenia (ITP): A Real Life Retrospective Multicenter Experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)

Background: The thrombopoietin receptor agonist eltrombopag has been shown to be safe and effective for children with chronic immune thrombocytopenia (ITP). The aim of the present study was to characterize eltrombopag use in current clinical practice. Material and Methods: This is a retrospective mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Giordano, Paola, Lassandro, Giuseppe, Barone, Angelica, Cesaro, Simone, Fotzi, Ilaria, Giona, Fiorina, Ladogana, Saverio, Miano, Maurizio, Marzollo, Antonio, Nardi, Margherita, Notarangelo, Lucia Dora, Pession, Andrea, Ruggiero, Antonio, Russo, Giovanna, Saracco, Paola, Spinelli, Marco, Tolva, Alessandra, Tornesello, Assunta, Palladino, Valentina, Del Vecchio, Giovanni Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059456/
https://www.ncbi.nlm.nih.gov/pubmed/32181255
http://dx.doi.org/10.3389/fmed.2020.00066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059456/
https://www.ncbi.nlm.nih.gov/pubmed/32181255
http://dx.doi.org/10.3389/fmed.2020.00066

Ejemplares similares